The importance of a central institutional review board in multicenter clinical trials: Richard D. Newman and Davin C. Gilson G.D. Searlr & Co., Skokie, Illinois (P10)
- 卷第9卷
- 期第3期
- 文件大小81.71KB
- 发表时间1988
- DOI10.1016/0197-2456(88)90144-4
同作者推荐
Superior Safety in Noninferiority TrialsDavid R. Bristol · 2005
Comparison of Two Exponential DistributionsDavid R. Bristol; M. M. Desu · 1990
CLINICAL EQUIVALENCEBristol, David R. · Journal of Biopharmaceutical Statistics · 1999
<i>P</i> -value adjustments for fubgroup analysesBristol, David R. · Journal of Biopharmaceutical Statistics · 1997
Author's ReplyBristol, David R. · Journal of Biopharmaceutical Statistics · 1998
Sample size determination using an interim analysisDavid R. Bristol · 1992
Sample size determination using an interim analysisBristol, David R. · Journal of Biopharmaceutical Statistics · 1993
Equivalence or Selection: A Distribution-Free ApproachM. M. Desu; David R. Bristol · 1985